AHRQ Director Defends U.S. Preventive Services Task Force
This article was originally published in The Gray Sheet
Executive SummaryAmid wide public outcry over new advice against routine screening for prostate cancer with prostate-specific antigen blood tests, Agency for Healthcare Research and Quality Director Carolyn Clancy is defending both the draft recommendations and the group that issued them, the U.S. Preventive Services Task Force.
You may also be interested in...
Consensus document issued on transcatheter heart valves. Boston Scientific launches Asia-Pacific organization. More news briefs.
New medicines under evaluation at the European Medicines Agency.